BridgeMD
New treatment option for Stroke with Hemiparesis
Official title Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
ClinicalTrials.gov ID: NCT06612359
What this study is testing
- What it's testing
- The overarching goal is to determine if the BOOST GAIT program can improve functional mobility in patients with stroke who are undergoing inpatient rehabilitation and have some walking function, through the application of augmented therapeutic exercises designed to achieve a normative gait pattern. The evaluation will be conducted using a combination of clinical scales and objective motion sensors that map walking quality and performance during activities of daily living, such as rising from a chair and standing.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- A first-ever unilateral stroke, infarction or bleeding
- Undergoing inpatient rehabilitation in the Jessa hospital, Herk-de-Stad
- Less than 3 months after stroke onset at the moment of inclusion
- 18 years of older
- Berg Balance Scale score 24 or higher (out of 56) at moment of inclusion
You likely can't join if
- Significant cognitive and/or speech impairments that markedly affect the comprehension and execution of instructions
See the full eligibility criteria
- A first-ever unilateral stroke, infarction or bleeding
- Undergoing inpatient rehabilitation in the Jessa hospital, Herk-de-Stad
- Less than 3 months after stroke onset at the moment of inclusion
- 18 years of older
- Berg Balance Scale score 24 or higher (out of 56) at moment of inclusion
- Timed Up-and-Go score 14 s or higher at moment of inclusion
- Functional Ambulation Category 3 or higher at moment of inclusion
- Understanding the goals and procedures of this study and giving informed consent
- Significant cognitive and/or speech impairments that markedly affect the comprehension and execution of instructions
The study team makes the final eligibility decision.
Where it's taking place
- Herk-de-Stad, Limburg, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Herk-de-Stad, Limburg, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.